Pure Global AI
NCT06221254Recruiting

A Smartphone Application for Added Psychological Wellbeing in Crohn's Disease

Israeli IBD Research Nucleus (IIRN) Consortium: COBMINDEX Goes Forward- A Smartphone Application for Added Psychological Wellbeing in Crohn's Disease
Soroka University Medical CenterClinicalTrials.govbehavioral
Verified
Study focus
Disease/Condition
Crohn Disease
Drug/Device/Intervention
COBMINDEX digital application
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Soroka University Medical Center
Location
Be'er Sheva,Haifa,Petah Tikva,Ramat Gan, Israel
Timeline & enrollment
Phase
N/A
Start date
Aug 01, 2023
End date
Aug 01, 2026
Enrollment
200 participants
Primary outcome

Effectiveness of application as compared to human therapist.

Summary

Psychological intervention by COBMINDEX application to reduce psychological stress among CD
 patients, fatigue and pain and improve the patients' well being, quality-of-life and
 disease-coping skills, as well as improvement of the patients' immunological profile and
 intestinal microbiome.

ICD-10 classifications
Crohn disease, unspecifiedOther Crohn diseaseCrohn disease of large intestineCrohn disease of small intestineCrohn disease [regional enteritis]
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06221254
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06221254 through Pure Global AI's free database. This phase not specified trial is sponsored by Soroka University Medical Center and is currently Recruiting. The study focuses on Crohn Disease. Target enrollment is 200 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.